A comparative study of stakeholder views on take-home naloxone services

被引:7
|
作者
Hill, Duncan [1 ]
Mcauley, Andrew [2 ]
机构
[1] NHS Lanarkshire, Motherwell ML1 2AF, Scotland
[2] NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow G2 2AF, Lanark, Scotland
关键词
Naloxone; take-home; stakeholders; INJECTION-DRUG USERS; FRANCISCO BAY AREA; HEROIN OVERDOSE; ACCEPTABILITY; INTERVENTION; PREVENTION; MANAGEMENT; ATTITUDES; DEATHS; IMPACT;
D O I
10.3109/14659891.2011.595275
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The limited research to date exploring views on naloxone provision has featured a range of stakeholders including staff, clients, family and carers. However, these studies are often conducted in isolated samples with limited scope for comparison. This study aimed to simultaneously explore and compare the views of clients, carers and professionals on naloxone distribution and the issues associated with it. Methods: Service providers, service-users and their family/friends were invited to complete a questionnaire which quantitatively measured their views on naloxone provision to service-users and their family/friends. Results: The majority of those surveyed felt that the supply of naloxone to service-users and their family/friends was a good idea and would help reduce drug-related deaths, but only after appropriate training on resuscitation techniques and administration of naloxone. Willingness to use the training and call an ambulance in an overdose situation were also high across all groups. Despite being at the highest risk of overdose, service-users were least likely to be aware of naloxone provision. Conclusions: There is strong support across stakeholders for the training and supply of naloxone to service-users and their family/friends. Despite this, awareness of naloxone and its uses, among service-users in particular, is limited and should be tackled as a priority.
引用
收藏
页码:430 / 441
页数:12
相关论文
共 50 条
  • [1] Take-home naloxone
    Kumar, Thara
    Rosenberg, Hans
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (37) : E1192 - E1192
  • [2] Take-home naloxone in Australia and beyond
    Olsen, Anna
    Dwyer, Robyn
    Lenton, Simon
    [J]. DRUG AND ALCOHOL REVIEW, 2018, 37 (04) : 437 - 439
  • [3] TAKE-HOME NALOXONE PILOT IN TASMANIA
    Greaves, Robyn
    [J]. DRUG AND ALCOHOL REVIEW, 2021, 40 : S37 - S37
  • [4] Rethinking 'carriage' of take-home naloxone
    McDonald, Rebecca
    Parkin, Stephen
    Eide, Desiree
    Neale, Joanne
    Clausen, Thomas
    Metrebian, Nicola
    Carter, Ben
    Strang, John
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 95
  • [5] TAKE-HOME NALOXONE SUPPLY IN QUEENSLAND
    Nuckey, Tegan
    Lintzeris, Nicholas
    Mackson, Judith
    Kelly, Liz
    [J]. DRUG AND ALCOHOL REVIEW, 2021, 40 : S37 - S37
  • [6] Take-home naloxone and the politics of care
    Farrugia, Adrian
    Fraser, Suzanne
    Dwyer, Robyn
    Fomiatti, Renae
    Neale, Joanne
    Dietze, Paul
    Strang, John
    [J]. SOCIOLOGY OF HEALTH & ILLNESS, 2019, 41 (02) : 427 - 443
  • [7] TAKE-HOME NALOXONE AND THE POLITICS OF CARE
    Farrugia, Adrian
    Fraser, Suzanne
    Dwyer, Robyn
    Fomiatti, Renae
    Neale, Joanne
    Dietze, Paul M.
    Strang, John
    [J]. DRUG AND ALCOHOL REVIEW, 2018, 37 : S31 - S31
  • [8] Take-home naloxone to reduce heroin death
    Baca, CT
    Grant, KJ
    [J]. ADDICTION, 2005, 100 (12) : 1823 - 1831
  • [9] Interest of take-home naloxone for opioid overdose
    Frauger, Elisabeth
    Kheloufi, Farid
    Boucherie, Quentin
    Monzon, Emilie
    Jupin, Leonard
    Richard, Nathalie
    Mallaret, Michel
    Micallef, Joelle
    [J]. THERAPIE, 2018, 73 (06): : 511 - 520
  • [10] Time for universal provision of take-home naloxone
    Crocker-Buque, Tim
    Lovitt, Chris
    [J]. LANCET, 2014, 384 (9940): : 308 - 308